Clinical Trial Update: Cardiac Electrophysiological Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial conducted by AstraZeneca evaluating a cardiac electrophysiological approach for atrial flutter has completed, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Flutter

Snippet

Sponsor: AstraZeneca | Conditions: Atrial Flutter | Phase 2 | Status: COMPLETED | Results posted: 2011-09-22